Cost of Hepatitis C Antivirals May Keep Patients Away
October 2, 2017
Closing in on cancer
October 3, 2017
Show all

The 8-Week Cure for Hepatitis C | Infectious Diseases 

There are now even shorter treatments for hepatitis C.

In less than a month, the FDA approved a second medication for hepatitis C virus (HCV) infection. The newer entry into the treatment arena is the first drug capable of suppressing viral load to undetectable levels in only 8 weeks.

Marketed as Mavyret, the recently approved medication is a combination of glecaprevir and pibrentasvir. Clinical trials involving about 2300 adults with any of the 6 HCV genotypes showed that 92% or more who received the combination for 8, 12, or 16 weeks had no detectable virus in their blood 12 weeks after treatment ended, suggesting their infections were cured.

Read full article: The 8-Week Cure for Hepatitis C | Infectious Diseases | JAMA | The JAMA Network

Read Full Article: The 8-Week Cure for Hepatitis C | Infectious Diseases | JAMA | The JAMA Network

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.